bendroflumethiazide has been researched along with Menopause in 8 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Sixty-three healthy women in their early menopause were randomized to treatment with bendroflumethiazide 5 mg/day or placebo for 2 yr, while both groups received placebo for the third year of the trial." | 5.05 | Thiazide for the postponement of postmenopausal bone loss. ( Christensen, MS; Christiansen, C; Jensen, GF; McNair, P; Transbøl, I, 1982) |
| " Nineteen healthy women in their early menopause were randomized for treatment with bendroflumethiazide (5 mg/d) (n = 11) or placebo (n = 8) for twelve months." | 5.05 | Actions of thiazide on vitamin D metabolism: a controlled therapeutic trial in normal women early in the postmenopause. ( Christiansen, C; Riis, B, 1985) |
| "Uric acid metabolism was studied in groups of early post-menopausal women before and during long-term administration of natural oestrogen/gestagen (n = 21), bendroflumethiazide (n = 19) or placebo (n = 34)." | 2.65 | Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women. ( Christiansen, C; Gotfredsen, A; Transbøl, I, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christiansen, C | 7 |
| Mazess, RB | 1 |
| Transbøl, I | 6 |
| Jensen, GF | 2 |
| Gotfredsen, A | 1 |
| Hagen, C | 3 |
| Christensen, MS | 4 |
| Stocklund, KE | 3 |
| McNair, P | 1 |
| Jensen, J | 1 |
| Rejnmark, L | 1 |
| Vestergaard, P | 1 |
| Heickendorff, L | 1 |
| Andreasen, F | 1 |
| Mosekilde, L | 1 |
| Riis, B | 1 |
5 trials available for bendroflumethiazide and Menopause
| Article | Year |
|---|---|
Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estrad | 1983 |
Thiazide for the postponement of postmenopausal bone loss.
Topics: Alkaline Phosphatase; Bendroflumethiazide; Bone and Bones; Calcium; Creatinine; Female; Humans; Meno | 1982 |
[Effects of natural estrogen/gestagen and thiazide on cardiovascular risk factors in normal menopausal women. A 2-year double-blind placebo study].
Topics: Adult; Bendroflumethiazide; Coronary Disease; Double-Blind Method; Estrogens; Female; Humans; Menopa | 1981 |
Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study.
Topics: Aged; Bendroflumethiazide; Biomarkers; Bone and Bones; Bumetanide; Calcitriol; Diuretics; Female; Hu | 2001 |
Actions of thiazide on vitamin D metabolism: a controlled therapeutic trial in normal women early in the postmenopause.
Topics: Bendroflumethiazide; Calcifediol; Calcitriol; Calcium; Clinical Trials as Topic; Dihydroxycholecalci | 1985 |
3 other studies available for bendroflumethiazide and Menopause
| Article | Year |
|---|---|
Factors in response to treatment of early postmenopausal bone loss.
Topics: Alkaline Phosphatase; Bendroflumethiazide; Bone and Bones; Calcium; Cholecalciferol; Estrogens; Fema | 1981 |
Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
Topics: Bendroflumethiazide; Climacteric; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; | 1982 |
Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study.
Topics: Adult; Bendroflumethiazide; Blood Glucose; Blood Pressure; Body Weight; Coronary Disease; Double-Bli | 1981 |